BRADLEY BROWN: Open Payments
NPI 1134519994 · SHEFFIELD, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$733 in 35 payments from 11 companies in 2025. Trend: 2023 $425 · 2024 $857 · 2025 $733
Food & beverage: $733
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 17 | $222 |
| Phathom Pharmaceuticals, Inc. | 3 | $153 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $139 |
| AstraZeneca Pharmaceuticals LP | 3 | $46 |
| Corcept Therapeutics | 2 | $39 |
| PFIZER INC. | 2 | $37 |
| Amgen Inc. | 2 | $29 |
| ABBVIE INC. | 1 | $20 |
| Dexcom, Inc. | 1 | $19 |
| Lundbeck LLC | 1 | $15 |
Products named: VOQUEZNA, CAPLYTA, Ozempic, Wegovy, Korlym, BREZTRI, PREVNAR 20, VRAYLAR.
Industry payments across AL — which companies pay providers there.
